Sponsor Dossier
Biocelect
Sponsor Dossier for Biocelect. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ACARIZAX
- Brand: GRAZAX
- Brand: IMOJEV
- Brand: JEXT
- Brand: KODATEF
- Brand: NUVAXOVID
- Brand: RAPIVAB
- Brand: Vaxchora
- Device (sponsor): Red cell metabolic enzyme IVDs
- Device (sponsor): Instrument/analyser IVDs
About
Biocelect is an Australian Private Company with ABN 88 168 092 171, registered in New South Wales. The entity is currently active.
Portfolio
Biocelect has nine brands on the ARTG, of which nine are indexable. All nine brands have Product Information on file. One brand has a PBAC outcome on record, and six brands have AusPARs on record. Notable brands include ACARIZAX, GRAZAX, IMOJEV, JEXT, KODATEF, NUVAXOVID, RAPIVAB, Vaxchora, and VIVOTIF. None of the portfolio is currently PBS-listed.
Therapeutic focus —
Infectious Disease: 5 brands — Immunology: 3 brands — Oncology: 1 brand
Regulatory activity
The latest AusPAR on record for Biocelect is from 31 January 2024, covering six brands. The latest PBAC outcome is from 1 November 2014, covering one brand.